Global Programme to Eliminate Lymphatic Filariasis ... - libdoc.who.int

1393.3.7 Surveys in sentinel sites and spot-check sitesResults of survey on microfilaraemia and disease prevalence carried out in the designated sentinel sites and spot-check sites in the programme area should be indicated inthe table below:Region ReferenceMDA IUSurveysiteDate ofsurveyYear of SentinelMDA a siteSpotchecksiteNo. ofpeopleexaminedfor microfilaraemiaMicrofilariapositivecasesNo. %MicrofilariareportedCoveragedensityper ml bby drugdistribu-Coveragecheckedin sitestors cHydrocelecases(%) dLymphoedemacasesCFANo. % No. % No. %aYear of MDA, i.e. 0 if before first MDA, year 2 if after the second MDA, etc.bVolume of blood recommended for microfilaria samples is 60 µl. If a different volume is used, the formula will need to be adjusted accordingly.cCoverage reported in sentinel sites (villages). It is recommended to evaluate around 500 people per site.dNo. of people who say they ingested the drugs/no. of people evaluated on site x 100. Coverage must be checked each year in each site (sentinel or spot-check). Assessment of approximately 500 people per siteshould be carried out within 7–21 days after MDA to ascertain the number of people who actually ingested the drugs.eCirculating filarial antigen tested using the immunochromatographic test (ICT) card.ANNEXES Annex 2 Revised Annual Report FormAnnual Report on Lymphatic Filariasis 2003